CD4+ T cells in sarcoidosis: targets and tools.
Activated pulmonary T-helper type 1 lymphocytes are essential for the inflammatory process in sarcoidosis. Both the T cells and their mediators promoting inflammation may constitute possible targets for immunotherapy. A particular T-cell subset, the T-cell receptor AV2S3(+) CD4(+) T cells, are found at dramatically increased levels in the bronchoalveolar lavage fluid of a subpopulation of sarcoidosis patients with active disease. This particular T-cell subset may be used as a tool to reveal a sarcoidosis-specific antigen. Recent studies of natural killer T cells and T regulatory cells from patients with sarcoidosis have described abnormalities that may be relevant for the inflammatory process in this disease. These findings are exciting news and may be of help for designing new treatment strategies.
Grunewald
Johan
J
Karolinska Institutet/Karolinska University Hospital, Lung Research Laboratory L4:01 Respiratory Medicine Unit, Department of Medicine, 171 76 Stockholm, Sweden. johan.grunewald@ki.se
Eklund
Anders
A
Wahlström
Jan
J